In an interview with Dr. Alaa Alhadad, head of Hospital 57357’s pediatric oncology department, published in Al Ahram newspaper, he reveals

    Bone marrow transplantation is one of the treatment options that contributed to a major leap in increased survival rate in Egypt, as we are following the same methods applied internationally.

Pediatric cancer overall survival rate exceeded 70%

Dr. Alaa Alhadad, former dean of the National Cancer Institute and head of Hospital 57357’s pediatric oncology department highlights that 57357 plays a major role in raising overall survival rates of children with cancer in Egypt. Currently, the rate exceeded 70% because the Hospital adopts latest international treatment protocols.

Bone marrow transplantation is one of the treatment options that contributed to a major leap in increased survival rate in Egypt, as we are following the same methods applied internationally.

To read the complete interview:  https://gate.ahram.org.eg/Massai/News/3536147.aspx